Synthetic Biology Market Share and Scope 2031
The synthetic biology market size is projected to reach US$ 66.4 billion by 2031 from US$ 15.1 billion in 2023. The market is expected to register a CAGR of 20.3% during 2023–2031. Advanced synthetic biology is likely to remain a key trend in the market.
Synthetic Biology Market Analysis
Key factors driving market growth are increasing investments in synthetic biology and the rising number of start-ups. Synthetic biology offers companies a broad scope of opportunities to collaborate inter-disciplinary globally between synthetic biologists, policymakers, researchers, and industry. For instance, in August 2021, Codex DNA announced a Synthetic Biology Collaboration with the U.S. Department of Agriculture to identify scalable therapeutic measures against citrus greening disease.
Synthetic Biology Market Overview
Synthetic biology is an emerging concept with numerous applications in the chemicals, agriculture, pharmaceuticals, and energy industries. Various start-ups offer solutions for complex microbial systems. For example, US-based startup Asimov offers a genetic design platform for mammalian synthetic biology. They integrate synthetic biology, multi-omics measurement, computational modeling, and machine learning in a single platform to advance therapeutic applications. Additionally, Benchling provides CAD tools, GenScript offers gene synthesis, Ginkgo Bioworks assists in organism engineering, Transcriptis (a bioinformatics company) offers solutions facilitating cloud labs/automation, and Glowee offers consumer products.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Synthetic Biology Market: Strategic Insights
Synthetic Biology Market
-
CAGR (2023 - 2031)
20.3%
-
Market Size 2023
US$ 15.1 Billion
-
Market Size 2031
US$ 66.4 Billion
Market Dynamics
GROWTH DRIVERS
- Increasing Investments in Synthetic Biology owing to various start-ups offer solutions for difficult microbial systems
FUTURE TRENDS
- Rising Number of Start-Ups
OPPORTUNITIES
- Collaboration between companies so they can collaborate inter-disciplinary globally between synthetic biologists, policymakers, researchers, and industry
Key Players
- THERMO FISHER SCIENTIFIC INC
- Agilent Technologies Inc
- MERCK KGaA
- New England Biolabs
- Integrated DNA Technologies
- Twist Bioscience
- GenScript Biotech Corporation
- Novozymes A S
- Codexis
Regional Overview
- North America
- Europe
- Asia-Pacific
- South and Central America
- Middle East and Africa
Market Segmentation
Products
- Enzymes
- Chassis Organisms
- Oligonucleotides
- Xeno-Nucleic Acids
Technology
- Measurement & Modeling
- Cloning & Sequencing
- Genome Engineering
- Gene Synthesis
- Nanotechnology
Application
- Medical Applications
- Industrial Applications
- Food
- Agriculture
- Environmental Applications
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Synthetic Biology Market: Strategic Insights
-
CAGR (2023 - 2031)20.3% -
Market Size 2023
US$ 15.1 Billion -
Market Size 2031
US$ 66.4 Billion
Market Dynamics
- Increasing Investments in Synthetic Biology owing to various start-ups offer solutions for difficult microbial systems
- Rising Number of Start-Ups
- Collaboration between companies so they can collaborate inter-disciplinary globally between synthetic biologists, policymakers, researchers, and industry
Key Players
- THERMO FISHER SCIENTIFIC INC
- Agilent Technologies Inc
- MERCK KGaA
- New England Biolabs
- Integrated DNA Technologies
- Twist Bioscience
- GenScript Biotech Corporation
- Novozymes A S
- Codexis
Regional Overview
- North America
- Europe
- Asia-Pacific
- South and Central America
- Middle East and Africa
Market Segmentation
- Enzymes
- Chassis Organisms
- Oligonucleotides
- Xeno-Nucleic Acids
- Measurement & Modeling
- Cloning & Sequencing
- Genome Engineering
- Gene Synthesis
- Nanotechnology
- Medical Applications
- Industrial Applications
- Food
- Agriculture
- Environmental Applications
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
Synthetic Biology Market Drivers and Opportunities
Rising Number of Start-Ups
Biotechnology entrepreneurs can quickly raise funds and procure equipment and space from governments in their countries. For instance, For instance, the Indian government financed IITM Bioincubator, a division of the Indian Institute of Technology Madras, to establish a bioinformatics infrastructure facility and a cutting-edge cancer biology research center. Organizations include the Department of Science and Technology (DST), the Department of Biotechnology (DBT), and the Council of Scientific and Industrial Research (CSIR) contributed the funding. In China, Chinaccelerator is a financer that provides mentorship programs to help start-ups. It is also associated with SOSV Investments LLC, which helps in the establishment of start-ups by providing funds through programs such as RebelBio and Indie Bio. The easy availability of funds for ideas motivates entrepreneurs worldwide to establish synthetic biology businesses.
Collaboration Between Companies
Synthetic biology is the branch of biotechnology that would provide opportunities for nearly every aspect of the healthcare sector, including drug delivery, protein therapeutics, biofuels, and food and agricultural product development. It provides opportunities for biotechnology entrepreneurs to accelerate discovery, reduce clinical failures, and be more cost-efficient. Synthetic biology offers companies a broad scope of opportunities to collaborate inter-disciplinary globally between synthetic biologists, policymakers, researchers, and industry. For instance, in August 2021, Riffyn Inc. and Imperial College’s Centre collaborated for Synthetic Biology (IC-CSynB), and SynbiCITE’s London Biofoundry sets for synthetic biology research and education in scientific reproducibility. These are the primary factors that make companies grow in the synthetic biology market and are likely to impact market growth in the forecast period.
Synthetic Biology Market Report Segmentation Analysis
Key segments that contributed to the derivation of the synthetic biology market analysis are product, technology, and application.
- Based on product, the synthetic biology market is segmented into enzymes, chassis organisms, oligonucleotides, and xeno-nucleic acids. The oligonucleotides segment held a larger market share in 2023.
- By technology, the market is segmented into measurement & modeling, cloning & sequencing, genome engineering, gene synthesis, nanotechnology, and others. The gene synthesis segment held the largest share of the market in 2023.
- By application, the market is segmented into medical applications, industrial applications, food and agriculture, environmental applications, and others. The medical applications segment held the largest share of the market in 2023.
Synthetic Biology Market Share Analysis by Geography
The geographic scope of the synthetic biology market report is mainly divided into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South & Central America.
Synthetic biology is a significant tool for biological advances, which provides potential for developing biological weapons, possible unforeseen negative impacts on human health, and any potential environmental impact. Security issues can be avoided by regulating industry biotechnology use through policy legislation.
The various government initiatives and funding offered are excellent support for the synthetic biology market's growth in the US. For instance, according to a National Center for Biotechnology Information (NCBI) report, the US government offers approximately US$220 million yearly for synthetic biology research and development. This fund includes investments from the Department of Energy, the National Science Foundation (NSF), the Department of Defense (DoD) (including DARPA), the National Institutes of Health (NIH), and the US Department of Agriculture (USDA).
Synthetic Biology Market Report Scope
Report Attribute | Details |
---|---|
Market size in 2023 | US$ 15.1 Billion |
Market Size by 2031 | US$ 66.4 Billion |
Global CAGR (2023 - 2031) | 20.3% |
Historical Data | 2021-2022 |
Forecast period | 2024-2031 |
Segments Covered |
By Products
|
Regions and Countries Covered | North America
|
Market leaders and key company profiles |
|
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
Synthetic Biology Market News and Recent Developments
The Synthetic Biology Market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the developments in the synthetic biology market are listed below:
- bit.bio and Ginkgo Bioworks announced bit.bio as an inaugural partner of the Ginkgo Technology Network. The Network, launched, is a groundbreaking ecosystem of cutting-edge technology partners committed to collaborating with Ginkgo to provide new, integrated capabilities to drive success in customer R&D programs. (Source: bit.bio, Company Website, February 2024)
- Sumitomo Chemical Co., Ltd and Ginkgo Bioworks announced a new program to develop functional chemicals with synthetic biology and expand upon the companies’ existing biomanufacturing partnership. (Source: Sumitomo Chemical Co., Ltd, Company Website, July 2023)
Synthetic Biology Market Report Coverage and Deliverables
The “Synthetic Biology Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering below areas:
- Synthetic biology market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Synthetic biology market trends as well as market dynamics such as drivers, restraints, and key opportunities
- Detailed PEST/Porter’s Five Forces and SWOT analysis
- Synthetic biology market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments.
- Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the synthetic biology market
- Detailed company profiles
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Products, Technology, and Application
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States
Frequently Asked Questions
North America dominated the synthetic biology market in 2023.
Key factors that are driving growth of the market are increasing investments in synthetic biology and rising number of start-ups in the market. However, the biosafety and biosecurity concerns in synthetic biology hamper the market growth.
Advanced synthetic biology is likely to remain a key trend in the market.
THERMO FISHER SCIENTIFIC INC, Agilent Technologies, Inc., MERCK KGaA, New England Biolabs, Integrated DNA Technologies, Twist Bioscience, GenScript Biotech Corporation, Novozymes A/S, Codexis.
The market is expected to register a CAGR of 20.3% during 2023–2031.